BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 24103483)

  • 1. Phosphatidic acid, phospholipase D and tumorigenesis.
    Gomez-Cambronero J
    Adv Biol Regul; 2014 Jan; 54():197-206. PubMed ID: 24103483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The exquisite regulation of PLD2 by a wealth of interacting proteins: S6K, Grb2, Sos, WASp and Rac2 (and a surprise discovery: PLD2 is a GEF).
    Gomez-Cambronero J
    Cell Signal; 2011 Dec; 23(12):1885-95. PubMed ID: 21740967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of phospholipase D suppresses taxotere-induced cell death in stomach cancer cells.
    Cho JH; Hong SK; Kim EY; Park SY; Park CH; Kim JM; Kwon OJ; Kwon SJ; Lee KS; Han JS
    Biochim Biophys Acta; 2008 May; 1783(5):912-23. PubMed ID: 18190795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased phospholipase D activity contributes to tumorigenesis in prostate cancer cell models.
    Borel M; Cuvillier O; Magne D; Mebarek S; Brizuela L
    Mol Cell Biochem; 2020 Oct; 473(1-2):263-279. PubMed ID: 32661773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phospholipase D in cell signaling: from a myriad of cell functions to cancer growth and metastasis.
    Gomez-Cambronero J
    J Biol Chem; 2014 Aug; 289(33):22557-22566. PubMed ID: 24990944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoregulation of phospholipase D activity is coupled to selective induction of phospholipase D1 expression to promote invasion of breast cancer cells.
    Kang DW; Park MH; Lee YJ; Kim HS; Lindsley CW; Alex Brown H; Min do S
    Int J Cancer; 2011 Feb; 128(4):805-16. PubMed ID: 20473892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure and regulation of human phospholipase D.
    Bowling FZ; Frohman MA; Airola MV
    Adv Biol Regul; 2021 Jan; 79():100783. PubMed ID: 33495125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PLD Protein-Protein Interactions With Signaling Molecules and Modulation by PA.
    Gomez-Cambronero J; Morris AJ; Henkels KM
    Methods Enzymol; 2017; 583():327-357. PubMed ID: 28063497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temporal production of the signaling lipid phosphatidic acid by phospholipase D2 determines the output of extracellular signal-regulated kinase signaling in cancer cells.
    Zhang F; Wang Z; Lu M; Yonekubo Y; Liang X; Zhang Y; Wu P; Zhou Y; Grinstein S; Hancock JF; Du G
    Mol Cell Biol; 2014 Jan; 34(1):84-95. PubMed ID: 24164897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phospholipase D as a key modulator of cancer progression.
    Yao Y; Wang X; Li H; Fan J; Qian X; Li H; Xu Y
    Biol Rev Camb Philos Soc; 2020 Aug; 95(4):911-935. PubMed ID: 32073216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proliferative and metastatic roles for Phospholipase D in mouse models of cancer.
    Roth E; Frohman MA
    Adv Biol Regul; 2018 Jan; 67():134-140. PubMed ID: 29154090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Participation of phospholipase D and alpha/beta-protein kinase C in growth factor-induced signalling in C3H10T1/2 fibroblasts.
    Thorsen VA; Vorland M; Bjørndal B; Bruland O; Holmsen H; Lillehaug JR
    Biochim Biophys Acta; 2003 Jun; 1632(1-3):62-71. PubMed ID: 12782152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phospholipase D2 promotes disease progression of renal cell carcinoma through the induction of angiogenin.
    Kandori S; Kojima T; Matsuoka T; Yoshino T; Sugiyama A; Nakamura E; Shimazui T; Funakoshi Y; Kanaho Y; Nishiyama H
    Cancer Sci; 2018 Jun; 109(6):1865-1875. PubMed ID: 29660846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reciprocal regulation of AMP-activated protein kinase and phospholipase D.
    Mukhopadhyay S; Saqcena M; Chatterjee A; Garcia A; Frias MA; Foster DA
    J Biol Chem; 2015 Mar; 290(11):6986-93. PubMed ID: 25632961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PLD-dependent phosphatidic acid microdomains are signaling platforms for podosome formation.
    Bolomini-Vittori M; Mennens SFB; Joosten B; Fransen J; Du G; van den Dries K; Cambi A
    Sci Rep; 2019 Mar; 9(1):3556. PubMed ID: 30837487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phospholipase D activates HIF-1-VEGF pathway via phosphatidic acid.
    Han S; Huh J; Kim W; Jeong S; Min do S; Jung Y
    Exp Mol Med; 2014 Dec; 46(12):e126. PubMed ID: 25523098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positive feedback regulation between phospholipase D and Wnt signaling promotes Wnt-driven anchorage-independent growth of colorectal cancer cells.
    Kang DW; Min do S
    PLoS One; 2010 Aug; 5(8):e12109. PubMed ID: 20711340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phospholipase D (PLD) drives cell invasion, tumor growth and metastasis in a human breast cancer xenograph model.
    Henkels KM; Boivin GP; Dudley ES; Berberich SJ; Gomez-Cambronero J
    Oncogene; 2013 Dec; 32(49):5551-62. PubMed ID: 23752189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding of the roles of phospholipase D and phosphatidic acid through their binding partners.
    Jang JH; Lee CS; Hwang D; Ryu SH
    Prog Lipid Res; 2012 Apr; 51(2):71-81. PubMed ID: 22212660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phospholipase D and the Mitogen Phosphatidic Acid in Human Disease: Inhibitors of PLD at the Crossroads of Phospholipid Biology and Cancer.
    Gomez-Cambronero J; Shah KN
    Handb Exp Pharmacol; 2020; 259():89-113. PubMed ID: 31541319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.